AGILENT TECHNOLOGIES, INC. A 74.57
Health Care · NYSE · Data as of 2026-09-01
AGILENT TECHNOLOGIES, INC. (A) has delivered +6.1% annualized revenue growth, +14.0% earnings growth, and +7.1% dividend growth over 10 years of data. Ranked #181 of 1968 stocks overall and #16 of 260 in the Health Care sector by Steady Score.
About AGILENT TECHNOLOGIES, INC.
Company Overview
Agilent Technologies provides instruments, software, consumables and services for laboratories. Its systems identify, measure and analyze chemical and biological substances using chromatography, mass spectrometry, spectroscopy, genomics and related techniques. Pharmaceutical and biotechnology companies, clinical laboratories, academic researchers, chemical producers, food-testing labs and environmental agencies use Agilent products in research, quality control and diagnostics.
Read more
Business Model & Revenue
Agilent earns revenue from instrument sales and from recurring consumables, supplies, software, maintenance and laboratory services. Life Sciences and Applied Markets sells analytical platforms; Agilent CrossLab supports installed instruments; Diagnostics and Genomics supplies pathology, companion-diagnostic and nucleic-acid products. Instrument demand follows laboratory capital budgets, while usage of the installed base supports repeat purchases and service contracts.
Key Facts & Market Position
The company combines high-value analytical instruments with columns, reagents, parts and expertise needed to keep laboratories operating. Its products often sit within regulated testing workflows, where method consistency and validation matter. Exposure spans research and routine production testing, reducing dependence on one application but linking results to pharmaceutical funding, industrial activity and government laboratory budgets.